Ujvira 160mg

Ujvira 160mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. It is used to treat adults with a type of breast cancer (human epidermal growth factor receptor 2 positive breast cancer) that has spread to other parts of the body or has not improved after treatment with other medications.

DOSE:-

Ujvira 160mg Injection is also given after surgery to kill any cancer cells left in the breast (adjuvant therapy). This medication is not recommended for adolescents and children under 18 years of age. Use effective birth control during the treatment and for at least seven months after the last dose,Instructions
How to use Ujvira 160mg Injection:

It will be given to you by a health care professional.